Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Go back to Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: UNCY) Delayed: 7.25 -0.44 (5.72%)
Previous Close $7.69    52 Week High
Open $7.69    52 Week Low
Day High $7.82    P/E N/A 
Day Low $7.24    EPS
Volume 953,921